CXCL5 and COVID-19: Thus, the chemokine antibody signature that distinguished healthy controls from COVID-19 convalescents (autoantibodies to CCL19, CCL22 and CXCL17) was different from the signature associated with COVID-19 severity (autoantibodies to CXCL5, CXCL8 and CCL25).